Drugs@FDA document

NAVSTEL Pediatric Medical Review · NDA 022193 ORIG-1

Drugs@FDA document · ALCON PHARMS LTD · Jan 1, 1900

Key facts

Drug name NAVSTEL
Document type Pediatric Medical Review
Application NDA022193
Submission ORIG-1
Company ALCON PHARMS LTD
Document date Jan 1, 1900

At a glance

  • 10–99 Documents for this application
  • 1–9 USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents